United States Minimally Invasive Surgery Devices Market: Market Size & Forecast 2026

The U.S. MIS devices market covers the hardware, instruments, imaging systems, and energy-based platforms used to perform surgical procedures through small incisions or natural orifices, including laparoscopic, endoscopic, and robotic-assisted surgery. The North American market, of which the U.S. forms the core, was valued at roughly $50.36 billion in 2025 and is forecast to grow at an 8.79% CAGR through the early 2030s. The U.S. accounts for the majority of North American revenue, supported by high per-capita healthcare spending, broad private and public insurance coverage, and a concentration of leading device manufacturers and academic medical centers. Independent estimates of market size vary widely because definitions differ across reports; some focus narrowly on instruments and access devices, while others include capital equipment, consumables, and robotic systems.

• •2025 North America market value: ~$50.36 billion; projected CAGR of 8.79%.
• •U.S. share dominates the regional market due to high healthcare expenditure and dense hospital networks.
• •Definitional differences across reports produce wide-ranging third-party size estimates for the segment.

Aging demographics are expanding the pool of patients eligible for MIS procedures, particularly in cardiac, orthopedic, urological, gynecological, and general surgery. Rising incidence of chronic conditions such as cardiovascular disease, obesity, cancer, and degenerative joint disease is increasing surgical volumes and shifting case mix toward minimally invasive approaches. Payer and patient preferences for outpatient and short-stay procedures, faster recovery, lower infection rates, and reduced postoperative pain continue to favor MIS over open surgery. Continuous product innovation in high-definition imaging, single-port platforms, handheld articulating instruments, and AI-enabled surgical planning is broadening the range of procedures that can be performed minimally invasively.

• •Aging U.S. population and rising chronic disease prevalence expand the surgical candidate pool.
• •Payer and patient demand for lower cost, faster recovery, and outpatient procedures accelerates MIS adoption.
• •Advances in imaging, energy devices, and robotic platforms extend MIS into more complex procedures.

The market is typically segmented by product (surgical instruments, electrosurgical and handheld devices, endoscopy/laparoscopy systems, and robotic surgical systems), by application (general surgery, orthopedics, cardiology, gynecology, urology, neurology, and others), and by end user (hospitals, ambulatory surgical centers, and specialty clinics). Within North America, the U.S. generates the bulk of revenue, while Canada and Mexico contribute smaller but growing shares as their hospital infrastructure modernizes. Robotic-assisted surgical systems and advanced endoscopy platforms represent the fastest-growing product categories, while conventional laparoscopic instruments remain the largest revenue segment by volume.

• •Hospitals are the leading end-user segment, with ambulatory surgical centers growing fastest.
• •General surgery, orthopedics, and gynecology are the largest application areas by procedure volume.
• •The U.S. accounts for the majority of North American revenue, with Canada and Mexico representing smaller growth markets.

What are the recent trends and outlook?

Adoption of robotic-assisted surgery is expanding beyond urology and gynecology into general surgery, thoracic, and orthopedic procedures, supported by new entrants and next-generation platforms. AI-driven surgical planning, image guidance, and intraoperative analytics are being integrated into endoscopy and robotic systems to improve precision and outcomes. Single-port and natural-orifice transluminal endoscopic surgery (NOTES) techniques, along with miniaturized flexible instruments, are extending MIS into previously hard-to-reach anatomies. Over the medium term, growth is expected to remain strong as hospitals prioritize outpatient-friendly technology, procedure volumes rise with an aging population, and reimbursement continues to support MIS approaches.

• •Robotic-assisted platforms are spreading from urology and gynecology into general, thoracic, and orthopedic surgery.
• •AI-enabled imaging, navigation, and intraoperative analytics are increasingly embedded in MIS systems.
• •Single-port and natural-orifice techniques, plus miniaturized instruments, are widening the range of MIS-eligible procedures.